These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14605330)

  • 1. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.
    Roest M; van der Schouw YT; Banga JD; Tempelman MJ; de Groot PG; Sixma JJ; Grobbee DE
    Circulation; 2000 Jan 4-11; 101(1):67-70. PubMed ID: 10618306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
    Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    J Am Coll Cardiol; 1999 Oct; 34(4):1176-83. PubMed ID: 10520809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
    Catto AJ; Carter AM; Stickland M; Bamford JM; Davies JA; Grant PJ
    Thromb Haemost; 1997 Apr; 77(4):730-4. PubMed ID: 9134651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly.
    Crainich P; Jenny NS; Tang Z; Arnold AM; Kuller LH; Manolio T; Sharrett AR; Tracy RP
    J Thromb Haemost; 2003 Aug; 1(8):1799-804. PubMed ID: 12911596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
    Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
    Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4G/5G Polymorphism of the plasminogen activator inhibitor-1 gene is associated with multiple organ dysfunction in critically ill patients.
    Huq MA; Takeyama N; Harada M; Miki Y; Takeuchi A; Inoue S; Nakagawa T; Kanou H; Hirakawa A; Noguchi H
    Acta Haematol; 2012; 127(2):72-80. PubMed ID: 22134139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
    Hindorff LA; Schwartz SM; Siscovick DS; Psaty BM; Longstreth WT; Reiner AP
    J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.
    von Känel R; Maly FE; Frey K; Fischer JE
    Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
    Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
    Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.
    Björck HM; Eriksson P; Alehagen U; De Basso R; Ljungberg LU; Persson K; Dahlström U; Länne T
    Am J Hypertens; 2011 Jul; 24(7):802-8. PubMed ID: 21490692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.